Do you know Da Nang Kidney Disease…Hallym University Sacred Heart Hospital Holds Free Open Lectures
Oct 17, 2025
Hallim University Sacred Heart Hospital (Hospital Director Kim Hyung-soo) will hold a 'Patient Class for Patients with Polycyst Kidney Disease and Their Families' at Ilsong Culture Hall in the hospital's second annex at 3 p.m. on November 4.
The event, jointly organized by the Korean Kidney Society and Hallim University Sacred Heart Hospital, was designed to provide correct disease information to patients and caregivers with polycystic kidney disease and to inform them of the importance of treatment and management. Open lectures are free of charge, and anyone with polycystic kidney disease or family can participate. You can apply in advance by QR code or phone on the event information poster.
Polycystic Kidney Disease (PKD) is a typical genetic disease that increases the size and function of the kidneys as several cysts (water lumps) form in the kidneys and gradually grow. Early diagnosis is difficult because there are no special symptoms in the early stages, but if the disease progresses, blood pressure rise, hematuria, abdominal pain, and abdominal bloating may occur. Early detection and steady management are known to be key to slowing the progression of the disease.
Ahn Jung-nam, a professor of kidney medicine at Hallim University Sacred Heart Hospital, will be the lecture speaker. Professor Ahn Jung-nam guides information such as the cause, diagnosis method, drug treatment, and life management of polycystic kidney disease at the patient's eye level under the theme of 'Understanding, Treatment, and Management of Diseases in Patients with Polycystic Kidney Disease'. After the lecture, a Q&A session will continue, providing time for patients and their families to ask questions directly and communicate with medical staff.
Professor Ahn Jung-nam said "Multi-cyst kidney disease is a chronic disease that requires lifelong management, but through accurate information and constant treatment, a sufficiently healthy life can be maintained."I hope this open lecture will serve as an opportunity for patients and their families to understand the disease correctly and take the lead in setting the direction of treatment" he said.
The event, jointly organized by the Korean Kidney Society and Hallim University Sacred Heart Hospital, was designed to provide correct disease information to patients and caregivers with polycystic kidney disease and to inform them of the importance of treatment and management. Open lectures are free of charge, and anyone with polycystic kidney disease or family can participate. You can apply in advance by QR code or phone on the event information poster.
Polycystic Kidney Disease (PKD) is a typical genetic disease that increases the size and function of the kidneys as several cysts (water lumps) form in the kidneys and gradually grow. Early diagnosis is difficult because there are no special symptoms in the early stages, but if the disease progresses, blood pressure rise, hematuria, abdominal pain, and abdominal bloating may occur. Early detection and steady management are known to be key to slowing the progression of the disease.
Ahn Jung-nam, a professor of kidney medicine at Hallim University Sacred Heart Hospital, will be the lecture speaker. Professor Ahn Jung-nam guides information such as the cause, diagnosis method, drug treatment, and life management of polycystic kidney disease at the patient's eye level under the theme of 'Understanding, Treatment, and Management of Diseases in Patients with Polycystic Kidney Disease'. After the lecture, a Q&A session will continue, providing time for patients and their families to ask questions directly and communicate with medical staff.
Professor Ahn Jung-nam said "Multi-cyst kidney disease is a chronic disease that requires lifelong management, but through accurate information and constant treatment, a sufficiently healthy life can be maintained."I hope this open lecture will serve as an opportunity for patients and their families to understand the disease correctly and take the lead in setting the direction of treatment" he said.
|
This article was translated by Naver AI translator.
